Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Hiyoshi, Yasuhiro, Nakahara, Yoshiro, Nishinarita, Noriko, Igawa, Satoshi, Naoki, Katsuhiko
Publicado 2019

Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer

por Shirasawa, Masayuki, Nakahara, Yoshiro, Niwa, Hideyuki, Harada, Shinya, Ozawa, Takahiro, Kusuhara, Seiichiro, Kasajima, Masashi, Hiyoshi, Yasuhiro, Sasaki, Jiichiro, Masuda, Noriyuki
Publicado 2016

Successful Chemotherapy with Nab-Paclitaxel in a Heavily Treated Non-Small Cell Lung Cancer Patient: A Case Report

por Ishihara, Mikiko, Igawa, Satoshi, Maki, Sachiyo, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Otani, Sakiko, Sasaki, Jiichiro, Jiang, Shi-Xu, Masuda, Noriyuki
Publicado 2014

Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

por Kusuhara, Seiichiro, Igawa, Satoshi, Ichinoe, Masaaki, Nagashio, Ryo, Kuchitsu, Yuki, Hiyoshi, Yasuhiro, Shiomi, Kazu, Murakumo, Yoshiki, Saegusa, Makoto, Satoh, Yukitoshi, Sato, Yuichi, Naoki, Katsuhiko
Publicado 2021

Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study

por Igawa, Satoshi, Ono, Taihei, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kusuhara, Seiichiro, Nishinarita, Noriko, Fukui, Tomoya, Kubota, Masaru, Sasaki, Jiichiro, Hisashi, Mitsufuji, Yokoba, Masanori, Katagiri, Masato, Naoki, Katsuhiko
Publicado 2019

Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an EGFR mutation: A prospective observat...

por Ono, Taihei, Igawa, Satoshi, Ozawa, Takahiro, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kusuhara, Seiichiro, Nishinarita, Noriko, Fukui, Tomoya, Kubota, Masaru, Sasaki, Jiichiro, Hisashi, Mitsufuji, Katagiri, Masato, Naoki, Katsuhiko
Publicado 2019

A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer

por Igawa, Satoshi, Kasajima, Masashi, Ono, Taihei, Ozawa, Takahiro, Kakegawa, Mikiko, Kusuhara, Seiichiro, Sato, Takashi, Nakahara, Yoshiro, Fukui, Tomoya, Yokoba, Masanori, Kubota, Masaru, Mitsufuji, Hisashi, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2021

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018

Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma

por Nakahara, Yoshiro, Fukui, Tomoya, Shirasawa, Masayuki, Harada, Shinya, Kusuhara, Seiichiro, Takakura, Akira, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Masuda, Noriyuki, Inukai, Madoka, Sekiguchi, Tomoko, Naoki, Katsuhiko
Publicado 2018

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Harada, Shinya, Nishinarita, Noriko, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2019

Prognostic significance of IMMT expression in surgically‐resected lung adenocarcinoma

por Hiyoshi, Yasuhiro, Sato, Yuichi, Ichinoe, Masaaki, Nagashio, Ryo, Hagiuda, Daisuke, Kobayashi, Makoto, Kusuhara, Seiichiro, Igawa, Satoshi, Shiomi, Kazu, Goshima, Naoki, Murakumo, Yoshiki, Saegusa, Makoto, Satoh, Yukitoshi, Masuda, Noriyuki, Naoki, Katsuhiko
Publicado 2019

Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab

por Fukui, Tomoya, Hosotani, Shinji, Soda, Itaru, Ozawa, Takahiro, Kusuhara, Seiichiro, Kakegawa, Mikiko I., Kasajima, Masashi, Hiyoshi, Yasuhiro, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Ishiyama, Hiromichi, Naoki, Katsuhiko
Publicado 2020

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease

por Igawa, Satoshi, Nishinarita, Noriko, Takakura, Akira, Ozawa, Takahiro, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Hosotani, Shinji, Sone, Hideyuki, Nakahara, Yoshiro, Fukui, Tomoya, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018